Singapore markets open in 4 hours 15 minutes

CollPlant Biotechnologies Ltd. (CLGN)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
5.20-0.04 (-0.76%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close5.24
Open5.22
Bid0.00 x 0
Ask0.00 x 0
Day's range5.20 - 5.22
52-week range4.22 - 8.90
Volume1,227
Avg. volume7,577
Market cap59.563M
Beta (5Y monthly)0.41
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • PR Newswire

    COLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

    CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived recombinant human collagen (rhCollagen) for tissue regeneration and organ manufacturing, today announced financial results for the full year ended December 31, 2023 and provided a corporate update.

  • PR Newswire

    COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

    CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen, today announced that it will report financial results for the full year of 2023 on Thursday, April 4, 2024, before the market open. The Company will then host a conference call and webcast to discuss its financial results and corporate updates on April 4th at 10:00 am Eastern Daylight Time.

  • PR Newswire

    CollPlant Issues Letter to Shareholders

    CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue regeneration and organ manufacturing, is pleased to issue the following letter from its Chief Executive Officer, Yehiel Tal.